MedTrace Logo

Intratumoral Holmium Microspheres Brachytherapy for Patients With Pancreatic Cancer

NCT05191498 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3

Last updated 2024-04-11

No results posted yet for this study

Summary

This is a feasibility study in which patients with pancreatic cancer are treated with intratumoral holmium microsphere injections.

Conditions

  • Pancreas Cancer

Interventions

DEVICE

QuiremSpheres®

Intratumoral injection of QuiremSpheres® up to a dose of 150 Gy.

Sponsors & Collaborators

  • Quirem Medical B.V.

    collaborator INDUSTRY

  • Radboud University Medical Center

    lead OTHER

Principal Investigators

  • Frank Nijsen, PhD · Associate professor

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-12-13
Primary Completion
2024-02-18
Completion
2024-02-18

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05191498 on ClinicalTrials.gov